Group 1 - The report predicts that both the macro short cycle and macro medium cycle in 2026 are likely to be in a bottom-up rising phase, forming an upward resonance pattern [2][14] - The GDP growth target for 2026 is expected to remain around 5%, with fiscal deficits and local special bonds likely to maintain levels similar to those in 2025 [18][20] - The upcoming National People's Congress and Chinese People's Political Consultative Conference in March 2026 will clarify fiscal and monetary policies for the year [18][22] Group 2 - The A-share market is expected to experience scattered hotspots in March 2026, with historical data from 2017 to 2025 indicating a generally downward trend in March [4][25] - The sectors that have shown significant performance in previous March months include professional services, fisheries, computer equipment, and IT services, which have low overlap with the technology and "anti-involution" sectors that performed well in early 2026 [4][30] - The report anticipates that the Hong Kong stock market will follow the A-share market and remain in a state of fluctuation due to various factors, including the expected stability of the RMB and the impact of the upcoming political meetings [5][36] Group 3 - The bond market is projected to show a "bear steepening" trend in March, supported by a continued moderately loose monetary policy and increased confidence from the political meetings [6][39] - In the commodity market, short-term volatility in crude oil prices is expected to increase due to geopolitical risks, while precious metals and strategic metals are still viewed positively [6][43] - The report highlights that the "anti-involution" and national security strategies are driving demand for strategic metals, which are becoming key production factors [43] Group 4 - Long-term investment strategies should focus on sectors benefiting from the "14th Five-Year Plan," particularly in new productive forces such as technology and environmental protection [7][44] - Short-term opportunities may arise in traditional sectors related to "anti-involution," while defensive long-term capital is expected to enter dividend-related sectors [7][45]

Industry Overview - The rare earth magnetic materials industry saw an increase of 8.84% in the week before the holiday, outperforming the benchmark by 8.48 percentage points [4] - The industry valuation (TTM P/E ratio) rebounded to 86.39x, currently at 93.3% of its historical percentile [4] Price Trends - Rare earth concentrate prices showed a steady increase, with the average price of mixed carbonate rare earth ore remaining stable, while imported monazite prices rose by 6.72% [5] - The price of praseodymium and neodymium saw significant increases, with praseodymium oxide prices up by 12.21% and praseodymium metal prices up by 10.38% [5] - Dysprosium and terbium prices also increased, with dysprosium oxide prices rising by 5.73% and terbium oxide prices by 3.49% [5] - The price of sintered neodymium-iron-boron magnets continued to rise, with N35 and H35 grades increasing by 1.73% and 1.23% respectively [5] Supply and Demand Dynamics - The supply side remains stable with upstream production normal during the holiday, while downstream neodymium-iron-boron enterprises are on break, leading to reduced market consumption [8] - Post-holiday, there is an expectation for increased raw material demand as production resumes in downstream sectors [8] - The demand for new energy vehicles is experiencing a marginal decline, while wind power installations are expected to release some demand [8] Investment Recommendations - The industry maintains an "overweight" rating, supported by high valuation levels and potential policy easing post-holiday [9] - Focus on upstream rare earth resource companies due to policy support and stable pricing trends, which may lead to valuation premiums and stable profits [9] - Downstream magnetic material companies are expected to see profit recovery, particularly those with strong customer structures and new growth opportunities [9]

Investment Rating - The industry investment rating is maintained at "Overweight" [3][8] Core Insights - The home appliance industry saw a slight increase of 0.16% from February 9 to February 13, ranking 19th among peers, while the CSI 300 index increased by 0.36% during the same period [4][9] - The overall market for home appliances is expected to decline in 2025, with a low base effect anticipated for 2026 [6] - The current valuation of the home appliance industry is at a historical low, with a price-to-earnings (PE) ratio of 15.40, ranking 26th among 31 industries [5][25] Summary by Sections Industry Performance - From February 9 to February 13, the home appliance sector increased by 0.16%, with "other black appliances" leading at +3.22% [4][17] - The top five gainers in the home appliance sector during this period were Tongxing Technology (+18.78%), Zhaochi Co. (+14.57%), *ST Gauss (+12.91%), Hongchang Technology (+7.69%), and Deep Konka A (+7.07%) [4][20] Market Trends - The home appliance market is projected to decline in 2025, with significant drops in new wind systems and major appliances, with the overall market size for refined decoration expected to decrease by 22.1% [6] - Midea has shown notable performance, improving its market share in several categories, including air conditioning and water heating systems [6] Valuation and Investment Strategy - The home appliance industry's PE ratio is 15.40, indicating a relatively low valuation compared to the CSI 300 index's PE of 13.31 [5][25] - Investment strategies focus on four main lines: enhancing operational efficiency in domestic competition, exploring new demands through innovative products, leveraging cost advantages in component manufacturing, and identifying "hidden champions" in the small appliance sector [7][53]

Group 1: Robotics Industry - Four companies showcased humanoid robots during the 2026 CCTV Spring Festival Gala, highlighting their operational control and collaborative capabilities [2] - The performance of humanoid robots demonstrated their emotional companionship value as household assistants, with significant increases in search and order volumes for related products following the event [2] - The collective appearance of these companies at a high-viewership event is expected to enhance public awareness and acceptance of humanoid robots, laying the groundwork for future commercialization [2] Group 2: Semiconductor Equipment Industry - A price increase for storage chips is anticipated, with Kioxia projecting a 50% rise in average selling prices for North American clients starting Q1 2026, potentially leading to a gross margin of 66% [3] - The global semiconductor sales are expected to reach approximately $78.88 billion by December 2025, reflecting a 37.1% year-on-year growth, driven by high demand from the AI sector [3][4] - The ongoing price increases in storage chips are likely to stimulate semiconductor companies to accelerate production, with domestic leaders expected to go public, further driving demand for semiconductor equipment [4] Group 3: Investment Recommendations - The manufacturing PMI in China decreased to 49.3% in January 2026, but policy support and measures to improve profitability are expected to gradually enhance manufacturing sentiment [5] - The humanoid robot sector is projected to experience rapid growth in product shipments, supported by the performance of leading companies during the Spring Festival Gala and the anticipated mass production of Tesla's Optimus V3 [5] - The semiconductor equipment sector is expected to maintain strong growth due to rising chip prices and ongoing domestic production initiatives, with a focus on leading companies in semiconductor equipment [5]

Investment Rating - The report maintains a "Buy" rating for the food and beverage industry [2] Core Insights - The food and beverage industry experienced a decline of 2.33% from February 9 to February 13, 2026, underperforming the CSI 300 index by 2.69 percentage points [6][9] - The industry is currently at a historical low valuation, with a PE ratio of 21X, ranking 24th among Shenwan's primary industries [5][18] - High-end liquor sales showed strong performance during the Spring Festival, with leading brands like Moutai and Wuliangye experiencing significant growth, while mid-range products faced a decline of approximately 20% [6][7] Summary by Sections Industry Performance - From February 9 to February 13, 2026, the food and beverage sector's relative return was -2.5% over one month, -5.3% over three months, and -21.6% over twelve months [4] - The overall market indices showed positive movement, with the Shanghai Composite Index up by 0.41% and the Shenzhen Component Index up by 1.39% during the same period [9] Valuation Metrics - As of February 13, 2026, the food and beverage industry's PE ratio stands at 21X, with sub-sectors like other alcoholic beverages (52X), snacks (37X), and health products (34X) having higher valuations, while liquor (19X), beer (22X), and dairy (23X) are lower [5][18] Investment Recommendations - The report suggests focusing on three main investment lines: 1. Industry leaders with stable demand and strong risk resilience 2. Companies actively developing new products, channels, and consumption scenarios 3. Segments of the mass consumer goods industry that have shown growth potential and reasonable valuations after adjustments [7][44] - Specific companies to watch include Moutai, Shanxi Fenjiu, Anjuke Foods, Andeli, Yanjinpuzi, Babi Foods, Yanjing Beer, and Yili [7][44]

Industry Overview - The pharmaceutical and biotechnology sector increased by 0.14% this week, ranking 15th among 31 primary industries in the Shenwan index, outperforming the CSI 300 index by 1.47 percentage points, which fell by 1.33% [2] - The medical services sub-sector reported a rise of 1.31%, while traditional Chinese medicine and medical commercial sectors also saw increases of 2.56% and 0.57%, respectively [2] Company Performance - Top-performing companies in the medical services sector included Meidisi (+18.0%), Tongce Medical (+8.1%), and NuoSiGe (+5.7%), while underperformers included Haoyuan Pharmaceutical (-6.2%) and Baicheng Pharmaceutical (-4.5%) [3] - CXO-related companies experienced significant pullbacks [3] Valuation Metrics - The medical services sector's price-to-earnings (PE) ratio is currently at 34.43X, with a one-year maximum of 41.13X and a minimum of 28.46X; the price-to-book (PB) ratio stands at 3.49X, with a one-year maximum of 4.00X and a minimum of 2.48X [5] - The PE ratio increased by 0.56X and the PB ratio by 0.06X compared to the previous week [5] Regulatory Developments - The National Health Commission approved a pilot program for internet-based first consultations in Beijing, focusing on pediatric specialties, which marks a significant regulatory advancement for internet healthcare in major cities [6] - This initiative is expected to enhance online medical services and provide new market opportunities for private healthcare providers [6] Investment Recommendations - The report maintains a "buy" rating for the medical services industry, suggesting a focus on high-growth areas such as ADC CDMO and weight-loss drug supply chains, as well as companies with improving profit expectations like Aier Eye Hospital and Dean Diagnostics [7] - The report emphasizes the importance of a multi-tiered payment system and the resilience of medical demand in stabilizing the industry [7]

Group 1: ETF Market Overview - As of February 6, 2026, there are 1,439 ETFs in the Shanghai and Shenzhen markets, with a total asset management scale of 53,280.88 billion [2] - The breakdown includes 1,116 stock ETFs (31,401.67 billion), 53 bond ETFs (7,213.28 billion), 27 money market ETFs (1,615.16 billion), 17 commodity ETFs (3,225.87 billion), 211 cross-border ETFs (9,760.39 billion), and 15 unlisted ETFs (64.51 billion) [2] - In the week from February 2 to February 6, 2026, 10 new stock ETFs were listed, including two photovoltaic ETFs and eight others, with a total issuance scale of 36.04 billion [3] Group 2: ETF Performance Analysis - The median weekly return for stock ETFs was -1.63%, with the Sci-Tech Innovation Board New Energy ETF showing the highest increase of 4.09%, while the Gold Stock ETF had the largest decline of 13.25% [4] - The median weekly return for bond ETFs was 0.06%, with the 30-year Treasury ETF increasing by 0.93% and the convertible bond ETF decreasing by 0.30% [4] - The median weekly return for cross-border ETFs was -2.39%, with the Hang Seng Consumer ETF showing the highest increase of 4.81%, while the Brazil ETF had the largest decline of 11.63% [4] Group 3: PB-ROE Framework and Strategy - The PB-ROE framework categorizes industries into six quadrants, focusing on high PB high ROE industries and low PB medium ROE industries for investment opportunities [5] - Backtesting from 2017 to February 2024 shows that only the third and fifth quadrants achieved excess returns, with annualized excess returns of 4.27% and 1.55%, respectively [5] - A combined strategy from both quadrants resulted in an annualized return of 11.93% and an annualized excess return of 13.22% [6] Group 4: Investment Recommendations - The report recommends focusing on the industries of non-ferrous metals, transportation, and public utilities, with corresponding ETFs for each sector [8] - Additionally, it suggests monitoring non-ferrous metals ETF, chemical ETF, software ETF, food and beverage ETF, and photovoltaic 50 ETF for the upcoming week [8]

1. Report Industry Investment Rating - No relevant content provided. 2. Core Viewpoints - In 2025, the number and scale of existing public - funds increased, and the ETF market was much more popular. The new - issuance quantity and share of ETFs increased significantly, with annual growth rates of 114.79% and 119.10% respectively, far exceeding the 37.00% increase in the total number and - 0.69% change in the total share of public funds [2][17]. - In Q4 2025, stock - type, bond - type, and hybrid - type funds generally showed a decrease in stock positions and an increase in bond positions. Public funds shifted from Hong Kong stocks and the Science and Technology Innovation Board to the Growth Enterprise Market [3]. - In Q4 2025, the industries with a relatively large increase in the active position - adjustment ratio were non - banking finance, non - ferrous metals, and communications, while those with a relatively large decrease were electronics, media, and biomedicine. There was an obvious shift from growth and consumption styles to the cyclical style [4]. - Since 2025, the scale of FOF funds has increased against the trend, and the proportion of bond - type funds in the top - five heavy - position funds of FOF in the Q4 2025 report is relatively high [6]. 3. Summary by Directory 3.1 Public Fund Market Overview 3.1.1 Fund Market Composition and Issuance - As of the end of Q4 2025, there were 13,618 public funds in the market, with an increase of 1,259 this year. In terms of quantity, they were mainly composed of hybrid, bond, and stock - type funds, accounting for 35.33%, 29.32%, and 25.33% respectively. The total scale was 37.67 trillion yuan, an increase of 4.84 trillion yuan compared to the end of 2024, with a 12.85% increase in Q4 2025. In terms of scale, they were mainly composed of money - market, bond, and stock - type funds, accounting for 39.84%, 29.50%, and 16.06% respectively [14]. - From 2021 to 2025, the number and share of newly - issued public funds showed a downward trend, but they increased in 2025. In Q4 2025, 406 public funds were newly issued, with a total issuance share of 280.081 billion shares. In terms of quantity, stock - type funds accounted for 47.29%, and in terms of share, stock - type and bond - type funds accounted for 31.70% and 31.24% respectively [15]. - In 2025, the new - issuance volume and share of ETFs increased significantly. In Q4 2025, the quarterly growth rates of the cumulative number and share of ETFs were 5.81% and 12.17% respectively, exceeding the 2.38% and 3.15% growth rates of public funds. The annual growth rates of the new - issuance quantity and share of ETFs in 2025 were 114.79% and 119.10% respectively, far higher than those of public funds [17]. 3.1.2 Investor Structure - According to the semi - annual report of public funds in 2025, the proportion of institutional holders changed little compared to 2024. The increase in the proportion of institutional investors was mainly reflected in QDII funds and hybrid - type funds, while the proportion of institutional investors in bond - type and hybrid funds increased slightly. The proportion of individual investors increased mainly in alternative investment funds and FOF funds, and also increased in money - market funds [20]. - As of mid - 2025, the holding net values of institutional and individual investors were 16.51 trillion yuan and 17.71 trillion yuan respectively, accounting for 48.25% and 51.75%. Since H2 2017, the proportion held by individual investors has been slightly higher than that by institutional investors [23]. 3.2 Stock - type Funds 3.2.1 Q4 Position Changes - In Q4 2025, compared with Q3, stock - type, bond - type, and hybrid - type funds generally showed a decrease in stock positions and an increase in bond positions, while FOF funds increased their stock positions, mainly in stock - type FOF funds, with an increase of 1.83 pct [25]. - The stock positions of four types of active funds (partial - stock hybrid, flexible allocation, common stock, and balanced hybrid) decreased, and their positions in Hong Kong stocks also decreased, but their bond positions increased [27][28]. 3.2.2 Sector Allocation - In Q4 2025, public funds shifted from Hong Kong stocks and the Science and Technology Innovation Board to the Growth Enterprise Market. The allocation market value of the Growth Enterprise Market increased by 2.65%, and the allocation ratio increased by 1.98%, reaching 18.61% at the end of Q4, second only to the main board [37]. 3.2.3 Industry and Style Allocation - In Q4 2025, 16 Shenwan primary industries had an increase in the active position - adjustment ratio, and 15 had a decrease. The industries with a relatively large increase were non - banking finance, non - ferrous metals, and communications, while those with a relatively large decrease were electronics, media, and biomedicine [43]. - There was an obvious shift from growth and consumption styles to the cyclical style in Q4 2025. The cyclical style had the largest increase in market - value proportion after removing the passive increase caused by the increase in Q4, with an active position - adjustment ratio increase of 2.06% [48]. 3.2.4 Individual Stock Allocation - As of the end of Q4 2025, the top 3 stocks in terms of market value of shares held were Zhongji Innolight, Xinyisheng, and Contemporary Amperex Technology, and the top 3 in terms of the proportion of market value of shares held to the floating market value were BeiGene - U, Reagent Biotech, and Ninebot Inc. - WD [4][49]. - In Q4 2025, the top 3 stocks with active position - increases were Ping An Insurance (Group) Company of China, Shandong Precision, and Tianhua New Energy, and the top 3 with active position - decreases were Foxconn Industrial Internet, Alibaba Group Holding Limited, and Semiconductor Manufacturing International Corporation [4]. 3.3 Bond - type Funds - As of the end of Q4 2025, there were 3,993 bond - type funds, an increase of 57 compared to the previous quarter, with a total scale of 11.11 trillion yuan, an increase of 373.431 billion yuan compared to the previous quarter. The increase in the scale was mainly due to the increase in the scale of passive index - type bond funds and hybrid bond - type secondary funds [63]. - In Q4 2025, except for convertible bond - type funds and enhanced index - type bond funds, the durations of other types of bond - type funds changed little. The durations of mixed - level - 1 bonds, mixed - level - 2 bonds, medium - and long - term pure - bond funds, and partial - bond hybrid funds showed a downward trend in the second half of 2025 after reaching a historical high at the end of Q2 2025 [5]. 3.4 FOF Funds - Since 2025, the scale of FOF funds has increased against the trend. In Q4 2025, the total scale of FOF funds increased by 50.699 billion yuan, with a faster growth rate than in Q3. The top 3 FOF funds in terms of scale proportion were partial - bond hybrid, partial - stock hybrid, and target - date FOF funds, accounting for 60.92%, 14.50%, and 11.01% respectively [70]. - Among the 43 FOF funds issued in Q4 2025, 41 were hybrid - type FOF funds. E Fund Ruyi Ying'an 6 - month Holding A had the largest issuance share of 3.164 billion shares [71]. - According to the top - ten heavy - position funds of FOF funds in the Q4 2025 report, the top - five heavy - position funds were all bond - type funds, and most of the FOF heavy - position funds were bond - type funds, with Haifutong CSI Short - term Financing Bond ETF having the highest total holding market value of 5.976 billion yuan [76].

Industry and Company Overview - The medical consumables sector showed a slight increase, with the sector index closing at 6067.61 points, up by 0.35% [2] - The performance of leading companies in the medical consumables sector included Maipu Medical (+8.5%), Hualan Biological (+7.5%), and Zhend Medical (+6.7%), while underperformers included Microelectrophysiology (-2.9%) and Daobo Medical (-3%) [2] Market Valuation Metrics - As of February 6, the medical consumables sector had a PE ratio of 36.1X, down by 0.23X from the previous week, with a one-year high of 40.1X and a low of 28.88X; the PB ratio was 2.61X, with a one-year high of 2.92X and a low of 2.13X [4] Recent Developments - Microelectrophysiology's product, a disposable intracardiac ultrasound imaging catheter, has been approved for market release, enhancing its core product offerings in cardiac intervention and filling a gap in integrated ultrasound imaging and electrophysiological mapping solutions [5] Investment Recommendations - There is a high certainty of continued performance recovery for some high-value consumable companies, driven by recent approvals of innovative products and overseas business development, which are expected to create new growth points outside of centralized procurement [6] - The report suggests focusing on leading companies with strong cost control and innovation capabilities, particularly in the orthopedic implants, cardiovascular intervention devices, and neurosurgical implants sectors, as well as those with advantages in rehabilitation and chronic disease management [6][7]

Investment Rating - The industry investment rating is "Overweight" (maintained) [4] Core Insights - The medical consumables sector saw a slight increase of 0.35% last week, with the sector index closing at 6067.61 points [6] - The PE ratio for the medical consumables sector is 36.1X, which is a decrease of 0.23X from the previous week, with a one-year maximum of 40.1X and a minimum of 28.88X [7] - The recent approval of innovative high-value consumables is expected to drive performance recovery and growth in the sector [21] Summary by Sections Industry Performance - The medical consumables sector outperformed the CSI 300 index by 1.47 percentage points, ranking 15th among the Shenwan first-level industries [6][10] - Over the past 12 months, the absolute return for the sector was 15%, while the relative return was -4% compared to the CSI 300 [5] Valuation Metrics - As of February 6, the sector's PB ratio stands at 2.61X, with a one-year maximum of 2.92X and a minimum of 2.13X [7][18] Industry Dynamics and Key Announcements - A new product, a disposable intracardiac ultrasound imaging catheter, has been approved, which integrates ultrasound imaging with catheter positioning information, enhancing diagnostic capabilities in cardiac procedures [20] - The approval of innovative products and the development of overseas markets are anticipated to provide new growth points for companies in the sector [21] Investment Recommendations - The report suggests closely monitoring the performance of innovative high-value consumables companies, particularly those with strong product lines and innovation capabilities, such as Huatai Medical, Microelectrophysiology, and Maipu Medical [21][23] - It also highlights the importance of companies that can improve their performance margins, particularly in the orthopedic consumables sector, such as Weigao Orthopedics [21][23]